A defect in thromboxane a2 synthesis may be a factor predisposing to cancer

References

1. • Karim S.M.M.
   • Rao B.
   Prostaglandins and tumours.
   in: Karim S.M.M. Prostaglandins: Physiological, Pharmacological and Pathological Aspects. MTP, Lancaster1976: 303
   • Google Scholar
2. • Jaffe B.M.
   Prostaglandins and cancer: an update.
   Prostaglandins. 1974; 6: 453
   • Google Scholar
3. • Easty G.C.
   • Easty D.M.
   Prostaglandins and cancer.
   Cancer Treat. Rev. 1976; 3: 217
   • Google Scholar
4. • Beerthuis R.K.
   • Nugteren D.H.
   • Pabon H.J.J.
   • van Dorp D.A.
   Biologically active prostaglandins from some new odd-numbered essential fatty acids.
   Rec. Trav. Chim. 1978; 87: 461
   • Google Scholar
5. • Mead J.F.
   • Fulco A.J.
   The Unsaturated and Polyunsaturated Fatty Acids in Health and Disease.
   CC Thomas, Springfield1976
   • Google Scholar
6. • Horrobin O.F.
   • Karmali R.A.
   • Manku M.S.
   • Ally A.I.
   • Karmazyn M.
   • Morgan R.O.
   Systemic lupus erythematosus: a disease of thromboxane A2 synthesis and action.
   IRCS J Med Sci. 1977; 5: 547
   • Google Scholar
7. • Nijkamp F.P.
   • Moncada S.
   • White H.L.
   • Vane J.R.
   Diversion of prostaglandin endoperoxide metabolism by selective inhibition of thromboxane A2 biosynthesis in lung, spleen or platelets.
   Eur J Pharmacol. 1977; 44: 179
   • Google Scholar
8. • Horrobin D.F.
   • Manku M.S.
   • Karmali R.A.
   • Oka M.
   • Ally A.I.
   • Morgan R.O.
   • Karmazyn M.
   • Cunnane S.C.
   Thromboxane A2: a key regulator of prostaglandin biosynthesis and of interactions between prostaglandins, calcium and cyclic nucleotides.
   Med Hypotheses. 1978; 4: 178
   • Google Scholar
9. • Warburg O.
   The Metabolism of Tumours.
   1930 (London)
   • Google Scholar
10. • Smith A.E.
    • Kenyon D.H.
    A unifying concept of carcinogenesis and its therapeutic implications.
    Oncology. 1973; 27: 459-479
    • Google Scholar
11. • Papaconstantinou I.
    • Colowick S.P.
    The role of glycolysis in the growth of tumour cells.
    J Biol Chem. 1961; 236: 278
    • Google Scholar
12. • Gold J.
    Cancer cachexia and gluconeogenesis.
    NY Acad Sci. 1974; 230: 103
    • Google Scholar
13. • Moncada S.
    • Bunting S.
    • Mullane K.
    • Thorogood P.
    • Vane J.R.
    • Raz A.
    • Needleman P.
    Imidazole: a selective inhibitor of thromboxane A2 synthetase.
    Prostaglandins. 1977; 13: 611
    • Google Scholar
14. • Parvin R.
    • Kalant N.
    Stimulation of glycolysis by imidazole.
    Life Sci. 1973; 13: 1347
    • Google Scholar
15. • Rossi E.C.
    The effect of imidazole upon platelets incubated in vitro.
    Thromb Diath Haemorrh. 1968; 19: 53-63
    • Google Scholar
16. • Loewenstein W.R.
    Some reflections on growth and differentiation.
    Perspect Biol Med. 1968; 11: 260
    • Google Scholar
17. • Burton A.C.
    Cellular communication, contact inhibition, cell clocks and cancer.
    Perspect Biol Med. 1968; 11: 260
    • Google Scholar
18. • Horrobin D.F.
    • Morgan R.O.
    • Karmali R.A.
    • Ally A.I.
    • Manku M.S.
    • Karmaqn M.
    • Cunnane S.C.
    Thymic changes in muscular dystrophy and evidence for an abnormality related to prostaglandin synthesis or action.
    Ann NY Acad Sci. 1978; (in press)
    • Google Scholar
19. • Horrobin D.F.
    • Manku M.S.
    • Ally A.I.
    • Morgan R.O.
    • Karmali R.A.
    Quinacrine as a prostaglandin antagonist.
    Biochem Biophys Res Commun. 1977; 76: 1188
    • Google Scholar
20. • Manku M.S.
    • Horrobin D.F.
    Chloroquine, quinine, procaine, quinidine and clomipramine are prostaglandin agonists and antagonists.
    Prostaglandins. 1976; 12: 789
    • Google Scholar
21. • Manku M.S.
    • Horrobin D.F.
    Chloroquine, quinine, procaine, quinidine, tricyclic antidepressants and methyl xanthines are prostaglandin agonists and antagonists.
    Lancet. 1976; 2: 1115
    • Google Scholar
22. • Karmali R.A.
    • Schiller P.
    • Horrobin D.F.
    Prostaglandins can prevent the binding of chloroquine to calf thymus DNA.
    Prostaglandins. 1976; 12: 463
    • Google Scholar
23. • Berenblum I.
    • Shubik P.
    A new quantitative approach to the study of the stages of chemical carcinogenesis in mouse skin.
    Br J Cancer. 1947; 1: 383
    • Google Scholar
24. • Greaves M.W.
    • Sondergaard J.
    Pharmacologic agents released in ultra violet inflammation studied by continuous perfusion.
    J Invest Dermatol. 1970; 54: 365
    • Google Scholar
25. • Snyder D.S.
    • Eaglestein W.H.
    Topical indomethacin and sunburn.
    Br J Dermatol. 1974; 90: 91-93
    • Google Scholar
26. • Manku M.S.
    • Horrobin D.F.
    Ultra violet radiation and 8-methoxypsoralen have actions similar to those of known inhibitors of thromboxane A2 synthesis in rat mesenteric blood vessels.
    Prostaglandins Med. 1978; 1: 87-96
    • Google Scholar
27. • Horrobin D.F.
    Prostaglandins: Physiology, Pharmacology and Clinical Significance.
    Churchill Livingstone, Edinburgh1978 (Eden Press, Montreal, in press)
    • Google Scholar
28. • Vittorio P.V.
    • Whitfield J.F.
    • Rixon R.H.
    The radioprotective, therapeutic effects of imidazole and erythropoietin on erythropoiesis and survivial and irradiated mice.
    Radiation Res. 1971; 47: 191-198
    • Google Scholar
29. • Mennie A.T.
    • Dalley V.M.
    • Dineen L.C.
    • Collier H.O.J.
    Treatment of radiationinduced gastrointestinal distress with acetyl salicylate.
    Lancet. 1975; ii: 942
    • Google Scholar
30. • Tai H.H.
    • Yuan B.
    On the inhibitory potency of imidazole and its derivatives on thromboxane synthetase.
    Biochem Biophys Res Comm. 1978; 80: 236-242
    • Google Scholar
31. • Weinstein I.B.
    • Wigler M.
    Cell culture studies provide new information on tumour promoters.
    Nature. 1977; 270: 659-660
    • Google Scholar
32. • Horrobin D.F.
    • Oka M.
    • Manku M.S.
    Effect of imidazole, histidine and colchicine on vascular reactivity: possible relevance to prostaglandin and thromboxane synthesis.
    Eur J Rheumatol. 1978; (in press)
    • Google Scholar
33. • O'Brien T.G.
    • Simsiman R.C.
    • Boutwell R.I.C.
    The effect of colchicine on the induction of ornithine decarboxylase by 12-0#tetradecanoyl phorbol13-acetate.
    Cancer Res. 1976; 36: 3766
    • Google Scholar
34. • Stern H.
    On the intranuclear environement.
    Science. 1955; 121: 144-146
    • Google Scholar
35. • Gerrard J.M.
    • Townsend D.
    • Stoddard S.
    • Witkop C.J.
    • White J.G.
    The influence of prostaglandin G2 on platelet ultrastructure and platelet secretion.
    Am J Path. 1977; 86: 99
    • Google Scholar
36. • Moss H.V.
    Xeroderma pigmentosum: report of 2 cases with metabolic studies.
    Arch Dermatol. 1965; 92: 638
    • Google Scholar
37. • Reed W.B.
    • May S.B.
    • Nickel W.R.
    Xeroderma pigmentosum with neurological complications.
    Arch Dermatol. 1965; 91: 224
    • Google Scholar
38. • Cleaver J.E.
    Xeroderma pigmentosum: a human disease in which an initial stage of DNA repair is defective.
    in: Proc Natl Acad Sci USA. 63. 1969: 428
    • Google Scholar
39. • Harris G.C.
    Malignancy during methotrexate and steroid therapy for psoriasis.
    Arch Dermatol. 1971; 103: 501
    • Google Scholar
40. • Sams W.M.
    Phototherapy of psoriasis.
    in: Fitzpatrick T.B. Sunlight and Man. University of Tokyo Press, 1974
    • Google Scholar
41. • Weber G.
    Combined 8-methoxypsoralen and black light therapy of psoriasis.
    Br J Dermatol. 1974; 90: 317-323
    • Google Scholar
42. • Horrobin O.F.
    • Manku M.S.
    • Karmali R.A.
    • Karmazyn M.
    • Morgan R.O.
    • Ally A.I.
    • Menezes J.
    Human interferon stimulates synthesis of prostaglandinlike material: effect blocked by cortisol.
    IRCS J Med Sci. 1977; 5: 554
    • Google Scholar